Evidence map›Paper›PMID 39994725›Full record

ArticleMolecular cancer2025

CircAKT3 promotes prostate cancer proliferation and metastasis by enhancing the binding of RPS27A and RPL11.

Xiaoming Song, Ziwei Wei, Cong Zhang, Dunsheng Han, Jinke Liu, Yufeng Song, Xuefeng Xie, Dingchang Shao, Mingkun Zhao, Fan Chao and 3 more

Abstract read
In one paragraph

Article in Molecular cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. NSUN2-mediated m5C hypermethylation ofNon-coding RNA research · 2025
    Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Xiaoming Song *Department of Urology, Jinshan Hospital, Fudan University, Shanghai, 201508, China.
Ziwei Wei *Department of Urology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China.
Cong ZhangDepartment of Urology, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, China.
Dunsheng HanDepartment of Urology, Jinshan Hospital, Fudan University, Shanghai, 201508, China.
Jinke LiuDepartment of Urology, Jinshan Hospital, Fudan University, Shanghai, 201508, China.
Yufeng SongDepartment of Urology, Jinshan Hospital, Fudan University, Shanghai, 201508, China.
Xuefeng XieDepartment of Urology, Jinshan Hospital, Fudan University, Shanghai, 201508, China.
Dingchang ShaoDepartment of Urology, Jinshan Hospital, Fudan University, Shanghai, 201508, China.
Mingkun ZhaoDepartment of Urology, Jinshan Hospital, Fudan University, Shanghai, 201508, China.
Fan ChaoDepartment of Urology, Zhongshan Hospital (Xiamen Branch), Fudan University, Xiamen, Fujian, 361015, China.
Guoxiong XuResearch Center for Clinical Medicine, Jinshan Hospital, Fudan University, Shanghai, 201508, China. guoxiong.xu@fudan.edu.cn.
Shiyu WangResearch Center for Clinical Medicine, Jinshan Hospital, Fudan University, Shanghai, 201508, China. sywang19@fudan.edu.cn.
Gang ChenDepartment of Urology, Jinshan Hospital, Fudan University, Shanghai, 201508, China. chen_gang@fudan.edu.cn.

Funding

National Natural Science Foundation of China 82303230Natural Science Foundation of Shanghai 22ZR1409700Project for Key Medical Specialty Construction Project in Jinshan District JSZK2023A03Project for Key Specialty Construction Project at Fudan University Jinshan Hospital ZDXK-2024-5
6 · The paper itself

Abstract

backgroundMetastatic prostate cancer (PCa) is a leading cause of mortality among PCa patients. Although circular RNAs (circRNAs) are recognized for their pivotal roles in tumorigenesis, the specifics of their influence within the context of PCa have yet to be fully elucidated.

methodsRT-qPCR was conducted to evaluate circAKT3 expression in PCa cells and in both tumor and adjacent noncancerous tissues. The oncogenic role of circAKT3 was confirmed through a combination of in vitro and in vivo experiments. Mechanistic investigations using RNA-pulldown, RNA immunoprecipitation (RIP), fluorescence in situ hybridization (FISH), immunofluorescence (IF), and Chromatin Immunoprecipitation (ChIP) assays explored how circAKT3 modulates c-Myc activity via interactions with RPS27A and RPL11. Additionally, Western Blotting and further in vitro and in vivo studies assessed circAKT3's influence on PCa progression through MST1.

resultsThis research identified the function and regulation of circAKT3, a circRNA derived from exons 2 to 8 of the kinase-b3 (AKT3) gene, in human PCa cells. CircAKT3 was significantly correlated with clinical indicators of disease severity, including D'Amico risk classification, the Gleason score, and pT stage. Both in vitro and in vivo experiments demonstrated that circAKT3 knockdown inhibited PCa cell proliferation, migration, and invasion. Lipid nanoparticles encapsulating si-circAKT3 (LNP-si-circAKT3) effectively suppressed the growth of bone tumors formed by PCa cells. Mechanistically, circAKT3 acted as a protein scaffold between ribosomal protein S27a (RPS27A) and ribosomal protein L11 (RPL11), promoting their cytoplasmic translocation and reducing nuclear RPL11 levels, ultimately diminishing RPL11's interaction with c-Myc and resulting in enhanced c-Myc-driven suppression of macrophage stimulating 1 (MST1) expression. Consequently, the decreased MST1 led to PCa progression and metastasis. CircAKT3 formation was facilitated by both flanking Alu elements and the RNA binding protein Quaking (QKI). Additionally, downregulation of the RNA helicase URH49 resulted in the nuclear accumulation of circAKT3, finally suppressing MST1 expression.

conclusionOur findings suggest that circAKT3 acts as a protein scaffold, promoting the interaction between RPS27A and RPL11, thereby influencing c-Myc activity and PCa progression. This study underscores the crucial role of circAKT3 in PCa and its potential as a therapeutic target to impede malignancy progression and metastasis.

Indexed as

Prostatic NeoplasmsRibosomal ProteinsRNA, CircularAnimalsCell Line, TumorCell MovementCell ProliferationGene Expression Regulation, NeoplasticHumansMaleMiceMice, NudeNeoplasm MetastasisProtein BindingProto-Oncogene Proteins c-aktAKT3 protein, humanProto-Oncogene Proteins c-aktribosomal protein L11Ribosomal ProteinsRNA, CircularCircAKT3C-MycMST1Prostate cancerRPL11RPS27A

Identifiers

PMID39994725
PMCPMC11852832

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.